We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
- Authors
Pancholi, Sunil; Leal, Mariana Ferreira; Ribas, Ricardo; Simigdala, Nikiana; Schuster, Eugene; Chateau-Joubert, Sophie; Zabaglo, Lila; Hills, Margaret; Dodson, Andrew; Gao, Qiong; Johnston, Stephen R.; Dowsett, Mitch; Cosulich, Sabina C.; Marangoni, Elisabetta; Martin, Lesley-Ann
- Abstract
After publication of the original article [1], we were notified that an author's surname has been erroneously spelled. Elisabetta Maragoni's family name should be replaced with Marangoni.
- Subjects
BREAST cancer; ESTROGEN; PERSONAL names; ESTROGEN antagonists
- Publication
Breast Cancer Research, 2020, Vol 22, Issue 1, p1
- ISSN
1465-5411
- Publication type
corrected article
- DOI
10.1186/s13058-020-1254-5